|
1
|
Hetz C, Martinon F, Rodriguez D and
Glimcher LH: The unfolded protein response: Integrating stress
signals through the stress sensor IRE1α. Physiol Rev. 91:1219–1243.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walter P and Ron D: The unfolded protein
response: From stress pathway to homeostatic regulation. Science.
334:1081–1086. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin JH, Walter P and Yen TS: Endoplasmic
reticulum stress in disease pathogenesis. Annu Rev Pathol.
3:399–425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Healy SJ, Gorman AM, Mousavi-Shafaei P,
Gupta S and Samali A: Targeting the endoplasmic reticulum-stress
response as an anticancer strategy. Eur J Pharmacol. 625:234–246.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Liu H, Huang YY, Pu LJ, Zhang XD,
Jiang CC and Jiang ZW: Suppression of endoplasmic reticulum
stress-induced invasion and migration of breast cancer cells
through the downregulation of heparanase. Int J Mol Med.
31:1234–1242. 2013.PubMed/NCBI
|
|
6
|
Nagelkerke A, Bussink J, Mujcic H, Wouters
BG, Lehmann S, Sweep FC and Span PN: Hypoxia stimulates migration
of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded
protein response. Breast Cancer Res. 15:R22013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Iliopoulos D, Zhang Q, Tang Q,
Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y, et
al: XBP1 promotes triple-negative breast cancer by controlling the
HIF1α pathway. Nature. 508:103–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wimmer R, Hohenester S, Pusl T, Denk GU,
Rust C and Beuers U: Tauroursodeoxycholic acid exerts
anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent
mechanism in rat liver. Gut. 57:1448–1454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vang S, Longley K, Steer CJ and Low WC:
The unexpected uses of urso- and tauroursodeoxycholic acid in the
treatment of non-liver diseases. Glob Adv Health Med. 3:58–69.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han YK, Lee JH, Park GY, Chun SH, Han JY,
Kim SD, Lee J, Lee CW, Yang K and Lee CG: A possible usage of a
CDK4 inhibitor for breast cancer stem cell-targeted therapy.
Biochem Biophys Res Commun. 430:1329–1333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yadav L, Puri N, Rastogi V, Satpute P,
Ahmad R and Kaur G: Matrix metalloproteinases and cancer-roles in
threat and therapy. Asian Pac J Cancer Prev. 15:1085–1091. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye Y, Zhou X, Li X, Tang Y, Sun Y and Fang
J: Inhibition of epidermal growth factor receptor signaling
prohibits metastasis of gastric cancer via downregulation of MMP7
and MMP13. Tumour Biol. 35:10891–10896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Wang S, Lu L and Wei G: MiR99a
modulates MMP7 and MMP13 to regulate invasiveness of Kaposi's
sarcoma. Tumour Biol. 35:12567–12573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chia SK, Wykoff CC, Watson PH, Han C, Leek
RD, Pastorek J, Gatter KC, Ratcliffe P and Harris AL: Prognostic
significance of a novel hypoxia-regulated marker, carbonic
anhydrase IX, in invasive breast carcinoma. J Clin Oncol.
19:3660–3668. 2001.PubMed/NCBI
|
|
16
|
Hockel M, Schlenger K, Aral B, Mitze M,
Schaffer U and Vaupel P: Association between tumor hypoxia and
malignant progression in advanced cancer of the uterine cervix.
Cancer Res. 56:4509–4515. 1996.PubMed/NCBI
|
|
17
|
Rademakers SE, Span PN, Kaanders JH, Sweep
FC, van der Kogel AJ and Bussink J: Molecular aspects of tumour
hypoxia. Mol Oncol. 2:41–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Y, László C, Liu Y, Liu W, Chen X,
Evans SC and Wu S: Regulation of G(1) arrest and apoptosis in
hypoxia by PERK and GCN2-mediated eIF2alpha phosphorylation.
Neoplasia. 12:61–68. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rouschop KM, Dubois LJ, Keulers TG, van
den Beucken T, Lambin P, Bussink J, van der Kogel AJ, Koritzinsky M
and Wouters BG: PERK/eIF2α signaling protects therapy resistant
hypoxic cells through induction of glutathione synthesis and
protection against ROS. Proc Natl Acad Sci USA. 110:4622–4627.
2013. View Article : Google Scholar : PubMed/NCBI
|
